Press release
Metabolomics Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities
Metabolomics
What Is the Projected Growth of the Lung Cancer Drugs Market?
The lung cancer drugs market has grown rapidly in recent years. It will grow from $47.94 billion in 2024 to $54.13 billion in 2025, at a CAGR of 12.9%. This growth can be attributed to factors such as epidemiological trends, demographic shifts, regulatory approvals, improvements in healthcare infrastructure, and increasing patient awareness and education.
The lung cancer drugs market is projected to see rapid growth in the next few years. It will reach $82.14 billion in 2029, with a compound annual growth rate (CAGR) of 11.0%. Growth is driven by health insurance and reimbursement policies, healthcare infrastructure, and emerging markets. Major trends include advancements in targeted therapies, immunotherapy, genomic profiling, and clinical research.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2567
What Are the Different Lung Cancer Drugs Market Segments?
The lung cancer drugs market covered in this report is segmented -
1) By Drugs: Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs
2) By Disease Type: Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC)
3) By End User: Hospitals, Clinics, Other End-Users
Subsegmentation:
1) By Gemzar: Generic Gemcitabine, Combination Therapies With Gemzar
2) By Paraplatin: Generic Carboplatin, Combination Therapies With Paraplatin
3) By Taxotere: Generic Docetaxel, Combination Therapies With Taxotere
4) By Navelbine: Generic Vinorelbine, Combination Therapies With Navelbine
5) By Avastin: Biosimilars Of Bevacizumab, Combination Therapies With Avastin
6) By Tarceva: Generic Erlotinib, Combination Therapies With Tarceva
7) By Iressa: Generic Gefitinib, Combination Therapies With Iressa
8) By Other Drugs: Immune Checkpoint Inhibitors (Pembrolizumab, Nivolumab), Targeted Therapies (Osimertinib, Crizotinib), Chemotherapy Drugs (Paclitaxel, Cisplatin)
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2567&type=smp
What Are the Primary Drivers Shaping the Lung Cancer Drugs Market?
The increasing rate of lung cancer cases is a key factor driving the lung cancer drugs market. This trend heightens the demand for effective treatment options and encourages the development of a robust drug pipeline. For example, the American Cancer Society reported in January 2023 that approximately 238,340 new lung cancer cases (117,550 in men and 120,790 in women) and around 127,070 related deaths (67,160 in men and 59,910 in women) were projected in 2023, highlighting the growing need for lung cancer drugs.
Which Companies Are Leading in the Lung Cancer Drugs Market?
Major companies operating in the lung cancer drugs market include Bristol-Myers Squibb Company, Merck & Co. Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., GlaxoSmithKline plc, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Celgene Corporation, Mylan N.V., Ono Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Ziopharm Oncology Inc., Menarini Group, AstraZeneca PLC, Shanghai Jinhe Bio-Technology Co. Ltd., Nlyte Software, AbbVie Inc., Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Eli Lilly and Company Inc., Johnson & Johnson, Amgen Inc., Array BioPharma Inc., Astellas Pharma Inc., Biogen Inc., Clovis Oncology Inc., Eisai Co. Ltd., Exelixis Inc., Genentech Inc., Gilead Sciences Inc., Incyte Corporation, Ipsen Biopharmaceuticals Inc., Jazz Pharmaceuticals plc, Karyopharm Therapeutics Inc., Kyowa Kirin Co. Ltd., Loxo Oncology Inc., MedImmune LLC
What Trends Are Expected to Dominate the Lung Cancer Drugs Market in the Next 5 Years?
The lung cancer drugs market is witnessing a trend toward combination therapies involving targeted drugs and immunotherapy. Merck and Co.'s pembrolizumab (Keytruda), when used with chemotherapy, has shown improved outcomes by helping the immune system detect and attack cancer cells more effectively.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report
What Are the Top Revenue-Generating Geographies in the Lung Cancer Drugs Market?
North America was the largest region in the lung cancer drugs market in 2023. Middle East is expected to be the fastest-growing region in the lung cancer drugs market during the forecast period. The regions covered in the lung cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Lung Cancer Drugs Market?
2. What is the CAGR expected in the Lung Cancer Drugs Market?
3. What Are the Key Innovations Transforming the Lung Cancer Drugs Industry?
4. Which Region Is Leading the Lung Cancer Drugs Market?
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metabolomics Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities here
News-ID: 4053719 • Views: …
More Releases from The Business Research Company
Segmentation, Major Trends, and Competitive Analysis of the Pervious Concrete Pa …
The pervious concrete pavers market is gaining notable traction as sustainable urban infrastructure becomes increasingly important. With advancements in technology and growing awareness about effective stormwater management, this sector is set to experience substantial growth and innovation. Let's explore the market size, key players, emerging trends, and segmentation details shaping the future of pervious concrete pavers.
Projected Market Size and Growth Outlook for the Pervious Concrete Pavers Market
The pervious concrete…
Market Trend Analysis: The Impact of Recent Innovations on the Old-Age Facilitie …
The old-age facilities construction sector is on the brink of remarkable growth, driven by technological advancements and evolving demands for senior care environments. As populations age worldwide, the need for innovative, efficient, and supportive living spaces is becoming increasingly important. This overview explores the projected market value, key industry players, emerging trends, and detailed market segmentation shaping this vital industry.
Future Market Valuation of the Old-Age Facilities Construction Market
The market…
Non-Resilient Flooring Market Overview, Key Trends, and Major Player Analysis
The non-resilient flooring sector is set for significant growth as demand rises for durable, aesthetically appealing, and technologically advanced flooring options. With innovations and sustainability becoming central to industry developments, this market is attracting attention from manufacturers and consumers alike. Let's explore the current market value projections, key players, trends, and segmentations shaping this dynamic industry.
Projected Market Value and Growth Outlook for the Non-Resilient Flooring Market
The non-resilient flooring market…
Competitive Landscape: Key Market Leaders and Emerging Companies in the Negative …
Exploring the promising future of sustainable construction, the negative carbon portland cement market is set to undergo remarkable transformation. With rising environmental concerns and technological innovations, this sector is gaining momentum and attracting significant investments. Here is an in-depth look at the market's anticipated growth, key players, technological trends, and segmentation analysis.
Negative Carbon Portland Cement Market Size and Projected Growth
The negative carbon portland cement market is expected to…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
